PRMT7 can prevent neurovascular uncoupling, blood-brain barrier permeability, and mitochondrial dysfunction in repetitive and mild traumatic brain injury.

Bioenergetics Blood-brain barrier Cerebral blood flow Gliosis Leukocyte rolling Mitochondrial dysfunction Protein arginine methyltransferase Traumatic brain injury

Journal

Experimental neurology
ISSN: 1090-2430
Titre abrégé: Exp Neurol
Pays: United States
ID NLM: 0370712

Informations de publication

Date de publication:
08 2023
Historique:
received: 19 03 2023
revised: 03 05 2023
accepted: 12 05 2023
medline: 13 6 2023
pubmed: 18 5 2023
entrez: 17 5 2023
Statut: ppublish

Résumé

Mild traumatic brain injury (TBI) comprises the largest percentage of TBI-related injuries, with pathophysiological and functional deficits that persist in a subset of TBI patients. In our three-hit paradigm of repetitive and mild traumatic brain injury (rmTBI), we observed neurovascular uncoupling via decreased red blood cell velocity, microvessel diameter, and leukocyte rolling velocity 3 days post-rmTBI via intra-vital two-photon laser scanning microscopy. Furthermore, our data suggest increased blood-brain barrier (BBB) permeability (leakage), with corresponding decrease in junctional protein expression post-rmTBI. Mitochondrial oxygen consumption rates (measured via Seahorse XFe24) were also altered 3 days post-rmTBI, along with disrupted mitochondrial dynamics of fission and fusion. Overall, these pathophysiological findings correlated with decreased protein arginine methyltransferase 7 (PRMT7) protein levels and activity post-rmTBI. Here, we increased PRMT7 levels in vivo to assess the role of the neurovasculature and mitochondria post-rmTBI. In vivo overexpression of PRMT7 using a neuronal specific AAV vector led to restoration of neurovascular coupling, prevented BBB leakage, and promoted mitochondrial respiration, altogether to suggest a protective and functional role of PRMT7 in rmTBI.

Identifiants

pubmed: 37196697
pii: S0014-4886(23)00130-9
doi: 10.1016/j.expneurol.2023.114445
pii:
doi:

Substances chimiques

PRMT7 protein, human EC 2.1.1.319
Protein-Arginine N-Methyltransferases EC 2.1.1.319

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114445

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS096225
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS126273
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christina H Acosta (CH)

Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Garrett A Clemons (GA)

Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Cristiane T Citadin (CT)

Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

William C Carr (WC)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Mariana Sayuri Berto Udo (MSB)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Vesna Tesic (V)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Henry W Sanicola (HW)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America; Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Anne H Freelin (AH)

Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Jamie B Toms (JB)

Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

J Dedrick Jordan (JD)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Bharat Guthikonda (B)

Department of Neurosurgery, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Krista M Rodgers (KM)

Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Celeste Yin-Chieh Wu (CY)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Reggie Hui-Chao Lee (RH)

Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.

Hung Wen Lin (HW)

Department of Cellular Biology & Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America; Department of Neurology, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America. Electronic address: hungwen.lin@lsuhs.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH